Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study

Blood Cancer J. 2021 May 21;11(5):100. doi: 10.1038/s41408-021-00491-7.

Tove Wästerlid^{1

2}, Sverker Hasselblom^{3

4}, Joel Joelsson^{5

6}, Caroline E Weibull⁵, Georgios Rassidakis⁷, Birgitta Sander⁸, Karin E Smedby^{5

6}

¹ Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. tove.wasterlid@ki.se.
² Department of Hematology, Karolinska University Hospital, Stockholm, Sweden. tove.wasterlid@ki.se.
³ Department of Research, Development & Education, Region Halland, Halmstad, Sweden.
⁴ Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
⁵ Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
⁶ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
⁷ Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
⁸ Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

No abstract available

Publication types